why choose us

First received: December 29, 2023

Clinical Trial: The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Panhypopituitarism

Study Type: INTERVENTIONAL


Official Title: The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Brief Summary: GLP-1 analogs are used as agents in the existing treatment of obesity.However, there are lack of previous reports on the effectiveness and role of GLP-1 analogs in the development of obesity traits in patients with functionally impaired hypothalamus.With this preliminary study, the investigators would explore the role of GLP-1 analogues to identify eating behavioral pathology subtype differences in the therapeutic efficacy of GLP-1 analogues in hypothalamic obesity patients.This will allow us to identify the role…

Read more